Athersys, Inc. (ATHX) Rating Reiterated by Maxim Group

Athersys, Inc. (ATHX) Rating Reiterated by Maxim Group


's stock had its "buy" rating reissued by equities researchers at Maxim Group in a report released on Sunday, AnalystRatings.Net reports. They currently have a $5.00 price target on the biopharmaceutical company's stock.



from Biotech News